GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKGAF) » Definitions » Payments of Debt

MKGAF (Merck KGaA) Payments of Debt : $-1,484 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Merck KGaA Payments of Debt?

Merck KGaA's Payments of Debt for the three months ended in Dec. 2024 was $-1,306 Mil.

Merck KGaA's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was $-1,484 Mil.


Merck KGaA Payments of Debt Historical Data

The historical data trend for Merck KGaA's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Payments of Debt Chart

Merck KGaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8,846.72 -2,944.63 -3,713.98 -1,945.47 -2,872.25

Merck KGaA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,062.16 -59.78 -118.41 - -1,305.76

Merck KGaA Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,484 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA Payments of Debt Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

From GuruFocus

Q2 2024 Merck KGaA Earnings Call Transcript

By GuruFocus Research 08-02-2024

Q3 2024 Merck KGaA Earnings Call Transcript

By GuruFocus News 11-15-2024

Q2 2022 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024

Q4 2023 Merck KGaA Earnings Press Conference Transcript

By GuruFocus Research 03-08-2024

Q1 2024 Merck KGaA Earnings Call Transcript

By GuruFocus Research 05-16-2024

Q1 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA Capital Markets Day Transcript

By GuruFocus Research 02-14-2024

Merck KGaA R&D Update Call Transcript

By GuruFocus Research 02-14-2024